Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 7
2004 8
2005 6
2006 6
2007 8
2008 8
2009 5
2010 5
2011 5
2012 12
2013 4
2014 3
2015 7
2016 11
2017 6
2018 6
2019 4
2020 14
2021 9
2022 5
2023 3
2024 2
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

131 results

Results by year

Filters applied: . Clear all
Page 1
Patients' and health care providers' perspectives on quality of hemophilia care in the Netherlands: a questionnaire and interview study.
Brands MR, Haverman L, Muis JJ, Driessens MHE, van der Meer FJM, Goedhart G, Meijer S, de Jong M, van der Bom JG, Cnossen MH, Fijnvandraat K, Gouw SC; HiN6 Steering Group; SYMPHONY consortium@SYMPHONY_NL; SYMPHONY consortium. Brands MR, et al. Among authors: van der meer fjm. Res Pract Thromb Haemost. 2023 Apr 23;7(4):100159. doi: 10.1016/j.rpth.2023.100159. eCollection 2023 May. Res Pract Thromb Haemost. 2023. PMID: 37346462 Free PMC article.
The Immediate Effect of COVID-19 Vaccination on Anticoagulation Control in Patients Using Vitamin K Antagonists.
Visser C, Biedermann JS, Nierman MC, van der Meer FJM, Gulpen AJW, Moors YCF, Cannegieter SC, Lijfering WM, Kruip MJHA; Dutch COVID & Thrombosis Coalition. Visser C, et al. Among authors: van der meer fjm. Thromb Haemost. 2022 Mar;122(3):377-385. doi: 10.1055/s-0042-1742628. Epub 2022 Mar 4. Thromb Haemost. 2022. PMID: 35245945 Free PMC article.
Switching from vitamin K antagonists to direct oral anticoagulants in non-valvular atrial fibrillation patients: Does low time in therapeutic range affect persistence?
Toorop MMA, Chen Q, Kruip MJHA, van der Meer FJM, Nierman MC, Faber L, Goede L, Cannegieter SC, Lijfering WM. Toorop MMA, et al. Among authors: van der meer fjm. J Thromb Haemost. 2022 Feb;20(2):339-352. doi: 10.1111/jth.15592. Epub 2021 Nov 23. J Thromb Haemost. 2022. PMID: 34779140 Free PMC article.
Stability of vitamin K antagonist anticoagulation after COVID-19 diagnosis.
Camilleri E, van Rein N, van der Meer FJM, Nierman MC, Lijfering WM, Cannegieter SC; Dutch Covid‐19 & Thrombosis Coalition. Camilleri E, et al. Among authors: van der meer fjm. Res Pract Thromb Haemost. 2021 Oct 13;5(7):e12597. doi: 10.1002/rth2.12597. eCollection 2021 Oct. Res Pract Thromb Haemost. 2021. PMID: 34667920 Free PMC article.
Perioperative pharmacokinetic-guided factor VIII concentrate dosing in haemophilia (OPTI-CLOT trial): an open-label, multicentre, randomised, controlled trial.
van Moort I, Preijers T, Bukkems LH, Hazendonk HCAM, van der Bom JG, Laros-van Gorkom BAP, Beckers EAM, Nieuwenhuizen L, van der Meer FJM, Ypma P, Coppens M, Fijnvandraat K, Schutgens REG, Meijer K, Leebeek FWG, Mathôt RAA, Cnossen MH; OPTI-CLOT study group. van Moort I, et al. Among authors: van der meer fjm. Lancet Haematol. 2021 Jul;8(7):e492-e502. doi: 10.1016/S2352-3026(21)00135-6. Lancet Haematol. 2021. PMID: 34171280 Clinical Trial.
131 results